CHICAGO (PRWEB) November 26, 2012
Matakina International today announced a partnership with Microsoft Corporation to make its revolutionary breast density assessment software available to users globally via the Microsoft Azure Cloud. As a result of the partnership, the company launched a Cloud-based version of its Volpara Breast Density Assessment software at the 98th Annual Meeting of the Radiology Society of North America, November 25-30, 2012. (RSNA Booth 6629 – South Hall).
Cleared by the FDA, HealthCanada, the TGA and CE-marked, Volpara is in use at sites across the globe helping radiologists assess breast density more objectively and helping them better consider who might benefit from additional screening.
“Knowledge of breast density and its implications are becoming the standard of care around the world, and the partnership with Microsoft allows us to offer our automated, objective breast density solution to any site connected to the Internet,” said Ralph Highnam, PhD, CEO of Matakina International. “Critically, it also offers us a simple way for national screening organizations to deploy our software securely in order to offer density assessment to millions of women at hundreds of facilities across multiple health systems or Enterprises.”
Until now, Volpara has been installed on individual workstations or as an Enterprise-wide solution where the software is installed on a central server. Driven by use of Volpara in a number of large clinical trials and national breast cancer screening programs worldwide, the additional Cloud-based option now offers secure, HIPAA-compliant access to the raw mammography acquisition data required to perform breast density assessment. And, for the first time, the Cloud-based version also enables facilities and researchers to store unlimited data.
“The Cloud also enables the ability to perform temporal analysis of breast density. Traditionally, facilities have not stored the raw data from which density measurement is performed. Now with long-term secure access to breast density data, an individual patient’s breast density values from one year could be compared with other years, which we believe could help detect cancers earlier by picking up the first signs of change,” said Professor Martin Yaffe, Professor of Biomedical Physics at the University of Toronto and one of the founders of Matakina.
“Microsoft is pleased to help enable the availability of objective breast density measurement on a global basis via the Cloud,” said Gabe Rijpma, Sr. Director Health Industry, Microsoft. “Cloud deployment is not only an ideal option for large multi-center institutions and national screening programs that require service across a wide geographic range, but also suits lower volume facilities because it requires no additional hardware and offers safe, secure access to this important breast cancer screening tool.”
Volpara is a reliable tool which generates objective, automatic measurement of volumetric breast density values under the Volpara Density Grade (VDG®) – a refined grading system which correlates with the American College of Radiology BIRADS Density Grading Classifications. Volpara is FDA cleared for all digital mammography units, and integration with other digital mammography systems, CAD systems and mammography reporting systems are also underway.
Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Matakina International, Limited is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand. Volpara’s founders and Board of Directors includes John Hood, PhD, former Vice Chancellor of the University of Oxford, UK; Ralph Highnam, PhD, former CEO of Mirada Solutions, one of the University of Oxford’s most successful spin-outs of recent times and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford where he was Professor of Information Technology for 25 years.
# # #
Chris K. Joseph